A comprehensive study involving more than 99 million people who received COVID-19 vaccines in eight countries (Argentina, Australia, Canada, Denmark, Finland, France, New Zealand and Scotland) was recently published. This research, which was part of the Global COVID Vaccine Safety project, aimed to determine if there were any significant health issues related to the vaccines. They specifically looked at 13 health problems, such as Guillain-Barré syndrome (a rare neurological disorder), blood clots, and heart inflammation.
The vaccines mostly showed safe results, but the study confirmed some rare side effects. For example, the Oxford/AstraZeneca vaccine showed a slightly higher risk of Guillain-Barré syndrome and a type of blood clot in the brain known as cerebral venous sinus thrombosis. However, these risks were not seen with mRNA vaccines like Pfizer and Moderna.
The study also found that heart inflammation (myocarditis and pericarditis) was more likely after Pfizer and Moderna vaccines, but this was extremely rare. Interestingly, there was a higher-than-expected occurrence of a brain condition called acute disseminated encephalomyelitis after the first dose of the Moderna vaccine, but this was based on a very small number of cases.
This large-scale study is crucial in identifying rare side effects of COVID-19 vaccines. Although there were some variations in the data due to different healthcare systems and study methods across countries, the overall findings are reassuring. They confirm that the known risks of COVID-19 vaccines are very rare and that the benefits outweigh the potential risks. Continuous monitoring and analysis of real-world data are important as vaccination programs continue worldwide.
Eliran Malki and Belong.Life Help People Navigate Cancer Care with an On-Demand AI Coach with…
Health system CFOs across the country face a unique quandary. Operating margins remain low, staffing…
The Perfect Storm: Challenges Driving Consumer Health Demand in APAC
The digital health sector has its ups and downs! Some judge its success by investment…
A growing body of evidence suggests that the fight against dementia should begin earlier, before…
AI has impacted the lives of everyone around the globe, but we can’t trust its…
This website uses cookies. Your continued use of the site is subject to the acceptance of these cookies. Please refer to our Privacy Policy for more information.
Read More